Bifidobacterium modulation of tumor immunotherapy and its mechanism

The advent of tumor immunotherapy in patients has revolutionized the treatment of tumors and significantly improved survival rates for a wide range of tumors. However, the full therapeutic potential of immune checkpoint inhibitors (ICIs) has yet to be realized, as not all patients have a lasting sur...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunology, Immunotherapy : CII Immunotherapy : CII, 2024-04, Vol.73 (5), p.94, Article 94
Main Authors: Pei, Bo, Peng, Shixuan, Huang, Chuying, Zhou, Fuxiang
Format: Article
Language:English
Subjects:
Antitumor activity
Bifidobacterium
Cancer Research
Clinical medicine
Humans
Immune Checkpoint Inhibitors
Immune system
Immunology
Immunomodulation
Immunotherapy
Malignancy
Medicine
Medicine & Public Health
Oncology
Patients
Probiotics
Review
Survival
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The advent of tumor immunotherapy in patients has revolutionized the treatment of tumors and significantly improved survival rates for a wide range of tumors. However, the full therapeutic potential of immune checkpoint inhibitors (ICIs) has yet to be realized, as not all patients have a lasting survival benefit from them, and a significant proportion of patients show primary or acquired resistance to immunotherapy. Bifidobacterium is one of the most common probiotics, and its antitumor and immunomodulatory effects have been demonstrated in recent years, but its immunomodulatory effects in tumors, especially on ICIs and in combination, have not been extensively studied in clinical practice, and its effects on the immune system and the mechanisms that modulate immunotherapy are largely unknown. Therefore, this review will focus on the immunomodulatory effects of Bifidobacteria in malignancies and the possible mechanisms of action of Bifidobacteria on immunotherapy in the hope of providing a basis for further research and better application of Bifidobacteria in clinical practice.
ISSN:1432-0851
0340-7004
1432-0851
DOI:10.1007/s00262-024-03665-x